Market Research Logo

Switzerland Pharmaceuticals and Healthcare Report Q2 2015

100 Pages BMI Research April 08, 2015 SKU: BMI5525837

Switzerland Pharmaceuticals and Healthcare Report Q2 2015

BMI View: Switzerland's epidemiological profile will continue to be attractive to manufacturers ofmedicines for non-communicable diseases. Despite the relative rapid uptake of innovative pharmaceuticals,the burden of chronic conditions will account for a large proportion of the total disease burden over thenext 15 years. Like many other developed states, Switzerland is introducing cost-containment measures torestrict the commercial opportunities presented to drugmakers.

Headline Expenditure Projections

Pharmaceuticals: CHF7.02bn (USD7.34bn) in 2014 to CHF6.96bn (USD7.16bn) in 2015; -0.81% inlocal currency terms and -2.4% in US dollar terms.

Healthcare: CHF69.64bn (USD72.81bn) in 2014 to CHF71.37bn (USD73.41bn) in 2015; +2.5% growthin local currency terms and +0.8% in US dollar terms.

Show Full Description


Show Table of Contents



Switzerland Pharmaceuticals and Healthcare Report Q2 2015

BMI Research
April 08, 2015

Pricing & Delivery

Report with 3 quarterly updates
$1,295
Report with 3 quarterly updates - 3 User License
$1,945
Report with 3 quarterly updates - 5 User License
$2,500
Report with 3 quarterly updates - Departmental/Site License
$2,995
Global Site License Fulfilled by Publisher
$6,995

Didn't find what you are looking for?

Let us find it for you. One of our knowledgeable research assistants will work with you to find exactly the right research to answer your questions:

US: 800.298.5699 International: +1.240.747.3093 Or leave us a message and we'll call you back!

Receive bi-weekly email alerts for new market research.



CTA Image

Download our free eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.


Download CTA

Share this report